Very early recurrence in pancreatic cancer: Redefining prognostic markers and surveillance strategies.

This editorial discusses the difficulties and challenges of managing pancreatic ductal adenocarcinoma. Approximately 50% of patients experience recurrence within one year after the curative-intent surgery as its highly lethal malignancy, the most sever outcome is very early recurrence (VER), which occurs within 12 weeks which reflects an aggressive tumor. The limitation of standards after surgery management in preventing VER, which significantly causes death in six-months (32.44% 14.77%) which highlights the urgent need of better predictive models to categorize patients. The study by Martlı which combines traditional statistical methods with machine learning to improve prediction accuracy. The findings from study highlights poorly differentiated (grade 3) tumor as the stronger predictor of VER. The research also presents an innovative association between VER and tumor present in pancreatic head. An abnormal red cell distribution width, a marker of systemic inflammation was also identified as a risk factor. The predictive accuracy has been increased by using random forest modelling which identifies nonlinear pattern in the data, reinforcing the importance of these factors. The clinical importance for these finding is significant; identifying patients with grade 3 tumors, pancreatic head tumors, or elevated red cell distribution width allows for tailored, intensive surveillance and consideration for the early initiation of adjuvant therapy. This editorial supports the combination of predictors with clinical practice to optimize treatment outcomes, and reduce the risk of VER, improve quality of life for patient population, while underscoring the need for multi-institutional validation and future molecular studies to further elucidate the mechanisms driving this aggressive disease.